Three different inhibitor concentrations were tested. Data are normalized to DMSO control as 100%. The dataset represents two independent experiments which were measured in triplicate (mean ± sd). pvalue was determined by Student's t-test. . Data represent two independent experiments which were measured in triplicate (mean ± sd).
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Fig. S4
Size-exclusion chromatograms of LmClpP2 treated with inhibitors. Treatment with Aoc-CMK, Leu-CMK and D3 results in retention of the tetradecamer whereas E2 and AV170 induce deoligomerization to heptamers. Tables   Table S1 Names and abbreviations Table S3 Peptidase activity of LmClpP variants (1 μM) with the substrates of the P2 library (100 μM AcAla-Xaa-Leu-ACC). Please refer to Table S1 for the names of non-natural amino acids. Data were measured in triplicates.
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Supplementary
a Peptide could not be obtained. Table S4 Peptidase activity of LmClpP variants (1 μM) with the substrates of the P3 library (100 μM AcXaa-hArg-Leu-ACC). Please refer to Table S1 for the names of non-natural amino acids. Data were measured in triplicates.
P2 amino acid
a Peptide could not be obtained. 
P3 amino acid
Biochemical Procedures
Cloning, protein overexpression LmClpP2, LmClpP2(S98A), LmClpP1(N172D) and SaClpP were obtained as described previously.
2-4
Expression constructs with C-terminal Strep-tag II were cloned in pET301 plasmids, overexpressed in E. coli BL21(DE3) and purified with affinity chromatography and gel filtration. 4 In short, C-terminally Strep-II-tagged LmClpP1 and C-terminally His6-tagged LmClpP2 were introduced into pETDuet-1 vector. Proteins were overexpressed in E. coli BL21(DE3) at 37 °C for 6 h after induction with 1 mM isopropyl-β-Dthiogalactoside (IPTG). After harvest the cells were lysed in His-lysis-buffer (20 mM MOPS, 100 mM KCl, 1% CHAPS, 5% glycerol, pH 8.0). The proteins from the cleared cell lysate were captured by Ni 2+ affinity chromatography in His buffers (20 mM MOPS, 100 mM KCl, 5% glycerol, pH 8.0, +40 mM imidazole for washing, +300 mM imidazole for elution) and a subsequent StrepTactin chromatography step in Strep buffers (100 mM Tris, 150 mM NaCl, 1 mM EDTA, pH 8.0, +2.5 mM desthiobiotin for elution). A final gel filtration was performed in LmClpP-GF buffer (20 mM MOPS, 100 mM KCl, 5% glycerol, pH 7.0).
Tagfree LmClpX was overexpressed in E. coli BL21(DE3) or in SG1146a (ΔclpP). In both cases, an expression construct equipped with an N-terminal His6-tag and a TEV cleavage site in pET300 vector was used. 4 4 L LB medium were inoculated (1:100) and grown to OD600 0.6 at 37 °C. After induction with 0.5 mM IPTG the cells were incubated over night at 25 °C. The cells were harvested by centrifugation, washed in PBS, resuspended in ClpX lysis buffer (25 mM HEPES, 200 mM KCl, 1 mM DTT, 5% glycerol, 0.5 mM ATP, 5 mM MgCl2, pH 7.6) and lysed by ultrasonication. The cell debris was removed by centrifugation (38,000 g, 40 min, 4 °C) and the cell lysate was loaded on a 5 mL HisTrap HP column (GE Healthcare) using an ÄKTA Purifier 10 system (GE Healthcare). The column was washed with 12 column volumes (CV) ClpX wash buffer (25 mM HEPES, 200 mM KCl, 1 mM DTT, 5% glycerol, 40 mM imidazole, pH 7.6). The protein was eluted with 6 CV ClpX elution buffer (25 mM HEPES, 200 mM KCl, 1 mM DTT, 5% glycerol, 300 mM imidazol, pH 7.6). The protein fractions were pooled, 1 mM EDTA and 1.25 mg TEV protease were added and the reaction mixture was incubated at 10 °C over night. The completeness of the TEV cleavage was verified by intact-protein mass-spectrometry. The protein solution was loaded on a Superdex 200 pg 16/60 column (GE Healthcare) and eluted in ClpX lysis buffer.
Tagfree SaClpX was purified as described previously. 5 In short, for the overexpression of SaClpX with an N-terminal His6-tag and TEV site pET301 vector was used in E. coli BL21(DE3) cells. The cell lysate was loaded on a HisTrap HP column (GE Healthcare). TEV protease and 1 mM EDTA were added to the pooled fractions. After cleavage and removal of imidazole, the protein solution was loaded on a HisTrap HP column and the flow-through was collected which was further purified by gel filtration.
N-terminally Strep-II-tagged eGFP with a C-terminal SsrA tag (AGKEKQNLAFAA for L. monocytogenes and AANDENYALAA for E. coli) was overexpressed in E. coli KY2266 (ΔclpXP, Δlon, ΔhslVU) 6 using pDEST007 expression vector and purified by affinity chromatography and gel filtration as described previously. 4, 5 GlyA (UniProt entry Q8Y4B2) and PncB (UniProt entry Q8Y826) with an N-terminal Strep-II tag and a Cterminal LmSsrA tag (AGKEKQNLAFAA) were constructed from L. monocytogenes EGD-e genomic DNA S12 in pDEST007 plasmid vector with Gateway® Technology using the primers listed in Table S5 . The plasmids were transformed into E. coli SG1146a cells. 2 L LB culture was induced with 0.2 μg/mL anhydroteracycline after reaching an OD600 of 0.6. GlyA was incubated at 37 °C for 5 hours and PncB at 25 °C over night. Cells were harvested by centrifugation, washed with PBS, resuspended in PBS and ultrasonicated on ice. The cell lysate was cleared by centrifugation (38,000 g, 40 min, 4 °C) and loaded on a pre-equlibrated 5 mL StrepTrap HP column (GE Healthcare). The column was washed with 6 CV binding buffer (100 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 8.0) and eluted with 5 CV binding buffer + 2.5 mM desthiobiotin. EcRpoS and SaGudB with SsrA tags (AANDENYALAA and AGKSNNNFAVAA, respectively) were purified similarly as described elsewhere. 7 Creatine kinase (10 127 566 001), lactate dehydrogenase (10 128 155 001) and pyruvate kinase (10 127 876 001) were purchased from Roche.
Peptidase assay
In the substrate library screening following fluorogenic tripeptide substrate libraries were used: AcAla-hArg-Xaa-ACC for P1 site, Ac-Ala-Xaa-Leu-ACC for P2 site and Ac-Xaa-hArg-Leu-ACC for P3 site. 1μL substrate (100x stock in DMSO, 100 μM final concentration) was added to a flat bottom black 96-well plate and equilibrated to 32 °C. LmClpP (1 μM) in preheated peptidase buffer (100 mM HEPES, 100 mM KCl, 15% glycerol, pH 7.0) was added to a final volume of 100 μL to start the reaction, and fluorescence (excitation: 380 nm, emission: 440 nm) was measured with an infinite M200Pro plate reader (Tecan). Data were recorded in triplicate.
For the testing of inhibitors 1 μL inhibitor (100x stock in DMSO, 1 μM, 10 μM and 100 μM final concentrations) and LmClpP (1 μM) in peptidase buffer (100 μL final volume) were incubated for 30 min at 32 °C. 1 μL (100x stock in DMSO, 200 μM final concentration) Ac-Ala-hArg-Leu-ACC substrate was added and the fluorescece was measured (380 nm, 430 nm). Data were recorded in triplicate and two independent experiments were performed.
Peptidase activity was determined by linear regression using Microsoft Excel and plots were made with Microcal OriginPro 2016.
Protease assay
Protease assays were carried out in flat bottom white 96-well plates in a final volume of 60 μL. 0.6 μL inhibitor (100x DMSO stock, 0.1 -100 μM final concentrations), ClpP14 (0.2 μM), ClpX6 (0.4 μM) and ATP regeneration mix (4 mM ATP, 16 mM creatine phosphate, 20 U/mL creatine kinase) were preincubated for 15 min at 30 °C in protease buffer (25 mM HEPES, 200 mM KCl, 5 mM MgCl2, 1 mM DTT, 10% glycerol, pH 7.6). 0.4 μM eGFP-SsrA substrate was added and fluorescence was measured (485 nm, 535 nm). Data were recorded in triplicate and at least two independent experiments were performed. Protease activity was determined by linear regression using Microsoft Excel and plots were made with Microcal OriginPro 2016.
For the determination of Kapp values the LmClpP14 concentration was varied (2 nM -8000 nM). If needed, Aoc-CMK (100x stock in DMSO, final concentration = 25×LmClpP14 concentration) or DMSO was added. In case of the GFP unfolding assay, LmClpP2(S98A) and LmClpP1(S98A)/LmClpP2(S98A) mutants were used in varying concentrations (10 nM -30 μM) in presence of 0.4 μM LmClpX6 and 0.125 μM eGFP-SsrA. Data were recorded in triplicate and at least two independent experiments were performed. Slopes were determined by linear regression using Microsoft Excel. Protease activity was plotted against LmClpP14 concentration in Microcal OriginPro 2016 and was fitted to the Hill equation:
ATPase assay 0.85 μL Aoc-CMK (100x DMSO stock, 4.25 μM final concentration) or DMSO were added to a flat bottom transparent 96-well plate. LmClpX6 (0.2 μM) and LmClpP214 (0.1 μM) were added in ATPase buffer (100 mM HEPES, 200 mM KCl, 20 mM MgCl2, 1 mM DTT, 1 mM NADH, 2 mM phosphoenolpyruvate, 50 U/mL lactate dehydrogenase, 50 U/mL pyruvate kinase, 5% glycerol, pH 7.5) and incubated for 12 min at 37 °C. The reaction was started by the addition of 20 mM ATP. Absorption at 340 nm was measured. Three independent experiments with four replicates each were carried out. ATPase activity was determined by linear regression using Microsoft Excel after substraction of the background signal (measurement without LmClpX), the plot was made with Microcal OriginPro 2016.
Analysis of LmClpXP protein substrate digests
LmClpP14 (0.2 μM), LmClpX6 (0.4 μM), SsrA-tagged substrate protein (1 μM) and ATP regeneration mix (4 mM ATP, 16 mM creatine phosphate, 20 U/mL creatine kinase) were incubated over night at 37 °C in protease buffer (25 mM HEPES, 200 mM KCl, 5 mM MgCl2, 1 mM DTT, 10% glycerol, pH 7.6).
The samples were desalted using reverse phase extraction cartridges (tC18 SepPak, 50 mg, Waters) on a vacuum manifold. Cartridges were washed three times with 1 mL acetonitrile (ACN), 1 mL 50% ACN with 0.5% formic acid (FA) and twice with 1 mL 0.1% FA. After addition of FA to a final concentration of 0.5% FA, the samples were loaded on the cartridges, washed with 1 mL 0.1% FA and twice with 1 mL 0.5% FA. Peptides were eluted into low binding reaction tubes (Eppendorf) with 3×200 μL 80% ACN with 0.5% FA. The eluates were vacuum dried. The dried samples were dissolved in 100 μL 1% FA, ultrasonicated for 15 min and filtered on a 0.45 μm pore size filter.
LC-MS/MS analysis was carried out on a Dionex UltiMate 3000 nano HPLC coupled to a Thermo Finnigan Orbitrap XL. Samples were loaded onto a C18 NanoTrap Column (Acclaim C18 PepMap100, 2 cm×10 μm i.d., 5 μm particle size, 300 Å pore size) and separated on a Dionex C18 PepMap RSLC (Acclaim C18 PepMap RSLC, 50 cm×75 μm i.d., 2 μm particle size, 100 Å pore size) column. Solvent A consisted of water + 0.1% FA + 5% DMSO and solvent B consisted of ACN + 0.1% FA + 5% DMSO. Separation was achieved at a constant flow rate of 0.2 µL/min using a gradient from 4% B to 30% B over 90 min and a subsequent wash-out to 80% B over 33 min. Full scans were carried out with an m/z range of 350 -1400 at a resolution of 60000 followed by a TOP5 CID fragmentation step (35 eV collision energy, activation time: 30 ms) using dynamic exclusion (30 s).
Fragmentation spectra were searched using the SEQUEST HT algorithm against a custom compiled proteome including contaminants using Proteome Discoverer 1.4. Cleavages were allowed after every amino acid, but the search was limited to monoisotopic precursor ions and a peptide mass tolerance of < 10 ppm. Oxidation (+15.995 Da) was set as dynamic modification at methionine residues in all
